Results 131 to 140 of about 8,505 (243)
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
British Journal of Pharmacology, Volume 183, Issue 14, Page 4006-4021, July 2026.Psychedelic drugs that activate 5‐HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics for treating psychiatric disorders has resurged recently and is well documented; less well recognised are their anti‐inflammatory properties. Growing evidence now demonstrates that psychedelics modulate immune
Omar Qureshi +10 more
wiley +1 more source
British Journal of Pharmacology, Volume 183, Issue 14, Page 4022-4047, July 2026.Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller +3 more
wiley +1 more source
Dialogues in Clinical NeuroscienceIntroduction Psychedelics are gaining recognition for their therapeutic potential in mental health treatment, yet societal attitudes remain divided, influenced by both skepticism and curiosity.
Paweł Holas +2 more
doaj +1 more source
Brain and Behavior, Volume 16, Issue 6, June 2026.Despite their capacity to bridge providers and clients, peer support workers remain largely absent from Australia's emerging psychedelic‐assisted therapy (PAT) landscape. This study identifies a broadly supportive and optimistic PSW workforce, while highlighting the need for tailored education pathways and structured integration models to enable ...
Aloysius Amos Lau +4 more
wiley +1 more source
PsychopharmacologyRationale. Anecdotal evidence suggests that psychedelic researchers often have personal experiences with psychedelic substances. While such experiences may benefit research, concerns have been raised about potential biases and “excessive enthusiasm.” However, the prevalence of personal experiences, their perceived relevance, and their association with ...
Jussi Jylkkä, Aila Mustamo
openaire +3 more sources
Brain and Behavior, Volume 16, Issue 6, June 2026.Individuals with treatment‐resistant depression considering psychedelic trial participation were motivated by chronic illness, failed treatments, and hope for a novel intervention, while actively minimizing expectations to guard against disappointment.
Christopher Poppe +3 more
wiley +1 more source
Ethical Considerations Regarding Psychedelics for Clinical Pain Research
Christopher L Robinson,1,* Matthew Slitzky,2,* Michael E Schatman,3,4 R Jason Yong,1 April D Lehman,5 Ata Murat Kaynar,6 Sharvari P Shivanekar,7 Trent Emerick6 1Department of Anesthesiology, Perioperative & Pain Medicine, Harvard Medical School ...
Kaynar AM +7 more
core
The therapeutic potentials of psychedelics
, 2017 In this dissertation; the history of the use of psychedelic substances, the studies concerning these substances, the methodologies and results of these studies, the future of the potential use of psychedelic substances, and the obstacles that scientists ...
Hajighanbari, Farnoosh
core
Energy‐Based Phase‐Locking State Analysis in Brain State Identification
Human Brain Mapping, Volume 47, Issue 8, June 1, 2026.EPLSA constructs an energy landscape from BOLD phase synchrony, achieving superior brain state classification and providing novel stability metrics. It demonstrates strong clinical translatability in characterizing sleep–wake transitions and Alzheimer's disease.
Chenfei Ye +6 more
wiley +1 more source